NCT04192682 2020-01-06
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University
Phase 2/3 Unknown
Clinical Trials
4 trialsNCT03239171 2019-01-25
Bioinformation Therapy for Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT00930891 2016-03-10
CPC
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3 Completed
NCT00168896 2006-02-14
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Charite University, Berlin, Germany
Phase 2/3 Unknown